Detection of GSSG/GSH, intracellular reactive oxygen species (ROS), and LC3 expression by elevation/ reduction of LAP3 expression to determine the role of LAP3 in NAFLD pathogenesis. This evidence concerns the gene MAP1LC3A and metabolic dysfunction-associated steatotic liver disease.